RE-BVS – Piemonte Repository

Sfoglia per AUTORE
BURLONE M
Collezione ASL Vercelli

Items : 7

A multi-center comparative study of Atezolizumab plus Bevacivumab and Lenvatinib as primary systemic therapy for unresectable hepatocellular carcinoma (HCC): focus on thrombotic and hemorrhagic adverse events in Digestive and Liver Disease

2024
ASL Vercelli

Tizzani M; Mazzarelli C; Burlone M; Carucci P; Caviglia GP; Lisi C; Canalis C; Cesarini L; Pirisi M; Acquaviva A; Rolle E; Pochettino P; Bencardino K; Villa F; Angiolillo M; Scaldaferri M; Castellana E; Cattel F; Airoldi M; Saracco GM; Gaia S;

Tolerability of first line systemic therapy in elderly patients with advanced hepatocellular carcinoma in Journal of Hepatology

2023
ASL Vercelli

Manfredi GF; Benedetto DD; Acquaviva A; Baorda F; Benedittis CD; Gerevini C; Rigamonti C; Burlone M; Pirisi M;

Red Cell Distribution Width and Platelet Count as Biomarkers of Pulmonary Arterial Hypertension in Patients with Connective Tissue Disorders. in Disease markers / Dis Markers. 2019 Jun 2;2019:4981982. doi: 10.1155/2019/4981982. eCollection 2019.

2019
ASL Vercelli
AOU Novara

Pirisi M; Marino P; Sola D; Smirne C; Burlone ME; Sguazzotti M; Grimoldi F; Dimagli A; Piccinino C; Giubertoni A; Bellan M; Sainaghi PP;

Improvement of insulin sensitivity in diabetic and non diabetic patients with chronic hepatitis C treated with direct antiviral agents. in PloS one / PLoS One. 2018 Dec 20;13(12):e0209216. doi: 10.1371/journal.pone.0209216. eCollection 2018.

2018
ASL Vercelli
AOU Novara

Bellomo G; Favretto S; Re A; Bianco S; Bonometti R; Burlone ME; Rigamonti C; Tran Minh M; Smirne C; Bellan M; Gualerzi A; Minisini R; Carnevale Schianca GP; Pirisi M;

Cardiac dysfunction as an early predictor of portal hypertension in chronic hepatitis C. in Annals of gastroenterology / Ann Gastroenterol. 2017;30(6):675-681. doi: 10.20524/aog.2017.0190. Epub 2017 Sep 6.

2017
ASL Vercelli
AOU Novara

Pirisi M; Franzosi L; Favretto S; Burlone ME; Giarda P; Minisini R; Bellan M; Marconi C;

17,?-estradiol inhibits hepatitis C virus mainly by interference with the release phase of its life cycle in Liver International

2016
ASL Vercelli

Magri A; Barbaglia MN; Foglia CZ; Boccato E; Burlone ME; Cole S; Giarda P; Grossini E; Patel AH; Minisini R; Pirisi M;

17,?-estradiol inhibits hepatitis C virus mainly by interference with the release phase of its life cycle in Liver International

2016
ASL Vercelli

Magri A; Barbaglia MN; Foglia CZ; Boccato E; Burlone ME; Cole S; Giarda P; Grossini E; Patel AH; Minisini R; Pirisi M;